Can your smartwatch really track blood pressure? new study puts wearables to the test
NCT ID NCT06610448
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares three new wearable blood pressure monitors (ABPMPro, Aktiia, and Spacelabs) to see how well they measure blood pressure and physical activity. One hundred adults with normal or high blood pressure will wear the devices for 48 hours. The goal is to find out if these newer, more convenient devices are as accurate as standard monitors.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify which wearable blood pressure monitors are accurate enough for everyday use, potentially improving how people track their blood pressure at home.
- What could go wrong
- This is a small, early-stage comparison study, not a treatment trial. The devices may not prove accurate enough for clinical use, and results may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 to 100 years * All neighborhoods in Boston area * Be able to walk with two limbs and have two arms * Willing and able to complete required measurement procedures * Able to provide informed consent Exclusion Criteria: * Failure to receive informed consent * Arm circumference of more than 50cm
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Controlled hypertension are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Neck implant aims to tame stubborn high blood pressure
- Can a new pill tame blood pressure that Won't budge?
- Zapping kidney nerves: a new hope for stubborn high blood pressure?
- New drug aims to tame stubborn high blood pressure
- New pill aims to tame stubborn high blood pressure
- New hope for stubborn high blood pressure: experimental drug SAL0140 enters phase 2 trial